Literature DB >> 11682501

Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.

R F Miller1, H E Ambrose, A E Wakefield.   

Abstract

The possible transmission of Pneumocystis carinii f. sp. hominis from patients with P. carinii pneumonia to asymptomatic health care workers (HCW), with or without occupational exposure to human immunodeficiency virus (HIV)-infected patients with P. carinii pneumonia, was examined. HCW in a specialist inpatient HIV-AIDS facility and a control group in the general medical-respiratory service in the same hospital provided induced sputum and/or nasal rinse samples, which were analyzed for the presence of P. carinii f. sp. hominis DNA by using DNA amplification (at the gene encoding the mitochondrial large subunit rRNA [mt LSU rRNA]). P. carinii f. sp. hominis DNA was detected in some HCW samples; those with the closest occupational contact were more likely to have detectable P. carinii DNA. P. carinii DNA was detected in one HCW who carried out bronchoscopy over a 2-year period. P. carinii-positive samples were genotyped by using DNA sequence variations at the internal transcribed spacer (ITS) regions of the nuclear rRNA operon, along with bronchoalveolar lavage samples from patients with P. carinii pneumonia hospitalized at the same time. Genotyping identified 31 different P. carinii f. sp. hominis ITS genotypes, 26 of which were found in the patient samples. Five of the eight ITS genotypes detected in HCW samples were not observed in the patient samples. The results suggested that HCW in close occupational contact with patients who had P. carinii pneumonia may have become colonized with P. carinii. Carriage was asymptomatic and did not result in the development of clinical disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682501      PMCID: PMC88458          DOI: 10.1128/JCM.39.11.3877-3882.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

1.  Pulmonary colonization with Pneumocystis carinii in human immunodeficiency virus-negative patients: assessing risk with blood CD4+ T cell counts.

Authors:  G Nevez; C Raccurt; P Vincent; V Jounieaux; E Dei-Cas
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

2.  Carriage of Pneumocystis carinii by immunosuppressed patients and molecular typing of the organisms.

Authors:  P M Hauser; D S Blanc; J Bille; A Nahimana; P Francioli
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

3.  Genetic diversity at the internal transcribed spacer regions of the rRNA operon among isolates of Pneumocystis carinii from AIDS patients with recurrent pneumonia.

Authors:  A G Tsolaki; R F Miller; A P Underwood; S Banerji; A E Wakefield
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

4.  Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers.

Authors:  S L Vargas; C A Ponce; F Gigliotti; A V Ulloa; S Prieto; M P Muñoz; W T Hughes
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

5.  Search for Pneumocystis carinii DNA in upper and lower respiratory tract of humans.

Authors:  H S Oz; W T Hughes
Journal:  Diagn Microbiol Infect Dis       Date:  2000-07       Impact factor: 2.803

6.  Genotyping of Pneumocystis carinii f. sp. hominis isolates in Japan based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes.

Authors:  N Hosoya; T Takahashi; M Wada; T Endo; T Nakamura; H Sakashita; K Kimura; K Ohnishi; Y Nakamura; T Mizuochi; A Iwamoto
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

7.  Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR.

Authors:  A Sing; A Roggenkamp; I B Autenrieth; J Heesemann
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping.

Authors:  J Helweg-Larsen; A G Tsolaki; R F Miller; B Lundgren; A E Wakefield
Journal:  QJM       Date:  1998-12

9.  Oropharyngeal samples for genotyping and monitoring response to treatment in AIDS patients with Pneumocystis carinii pneumonia.

Authors:  Anthony G Tsolaki; Robert F Miller; Ann E Wakefield
Journal:  J Med Microbiol       Date:  1999-10       Impact factor: 2.472

10.  Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission.

Authors:  C B Beard; J L Carter; S P Keely; L Huang; N J Pieniazek; I N Moura; J M Roberts; A W Hightower; M S Bens; A R Freeman; S Lee; J R Stringer; J S Duchin; C del Rio; D Rimland; R P Baughman; D A Levy; V J Dietz; P Simon; T R Navin
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

View more
  35 in total

1.  Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom.

Authors:  Robert F Miller; Austin R Lindley; Helen E Ambrose; Adam S Malin; Ann E Wakefield
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 2.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

3.  Pneumocystis jirovecii airborne transmission between critically ill patients and health care workers.

Authors:  Sandrine Valade; Elie Azoulay; Céline Damiani; Francis Derouin; Anne Totet; Jean Menotti
Journal:  Intensive Care Med       Date:  2015-05-05       Impact factor: 17.440

4.  Genotypes at the internal transcribed spacers of the nuclear rRNA operon of Pneumocystis jiroveci in nonimmunosuppressed infants without severe pneumonia.

Authors:  Anne Totet; Jean-Claude Pautard; Christian Raccurt; Patricia Roux; Gilles Nevez
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

Review 5.  Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis.

Authors:  James A Grubbs; John W Baddley
Journal:  Curr Rheumatol Rep       Date:  2014-10       Impact factor: 4.592

6.  Pneumocystis jerovecii pneumonia in a patient with untreated chronic lymphocytic leukaemia: a novel case and postulations concerning the mechanism.

Authors:  Alexandros Kalkanis; Marc A Judson; Mark B Napier
Journal:  BMJ Case Rep       Date:  2013-11-28

7.  Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study.

Authors:  N A Maskell; D J Waine; A Lindley; J C T Pepperell; A E Wakefield; R F Miller; R J O Davies
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

8.  Genotypic variation in Pneumocystis jirovecii isolates in Britain.

Authors:  R F Miller; A R Lindley; A Copas; H E Ambrose; R J O Davies; A E Wakefield
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

9.  Pneumocystis jirovecii transmission from immunocompetent carriers to infant.

Authors:  Laura Rivero; Carmen de la Horra; Marco A Montes-Cano; Alfonso Rodríguez-Herrera; Nieves Respaldiza; Vicente Friaza; Rubén Morilla; Sonia Gutiérrez; José M Varela; Francisco J Medrano; Enrique J Calderón
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

10.  Healthcare worker occupation and immune response to Pneumocystis jirovecii.

Authors:  Renuka Tipirneni; Kieran R Daly; Leah G Jarlsberg; Judy V Koch; Alexandra Swartzman; Brenna M Roth; Peter D Walzer; Laurence Huang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.